Significance of primary hyperparathyroidism in the management of osteoporosis

This publication has 45 references indexed in Scilit:

• Parathyroid hormone. Does it have a role in the pathogenesis of osteoporosis?
  Clinics In Laboratory Medicine, 2000
• PRIMARY HYPERPARATHYROIDISM
  Endocrinology and Metabolism Clinics of North America, 2000
• Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells
  Acta Endocrinologica, 2000
• A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo
  Endocrinology, 1999
• Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
  Endocrine Reviews, 1999
• The role of integrins in osteoclast function.
  Journal of Bone and Mineral Metabolism, 1999
• Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells
  Endocrinology, 1998
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
  Proceedings of the National Academy of Sciences, 1998
• Primary Hyperparathyroidism: Still Evolving?
  Journal of Bone and Mineral Research, 1997
• Regulation of cytokine expression in osteoblasts by parathyroid hormone: Rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA
  Journal of Bone and Mineral Research, 1993